KEY ADVISORS

RESEARCH ADVISORY TEAM

• Inder M. Verma, Ph.D., Director, Laboratory of Genetics at The Salk Institute
• Carl H. June, M.D.,  Director, Translational Research at the Abramson Cancer Center, University of Pennsylvania
• R. Jude Samulski, Ph.D., Director, Gene Therapy Center, University of North Carolina at Chapel Hill
• John J. Rossi, Ph.D., Chair and Professor, Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope
• Ian Alexander, M.D., Ph.D., Professor, Paediatrics & Molecular Medicine, University of Sydney/Children's Hospital at Westmead, Sydney, Australia
• David Ma, M.D., Director, Blood Stem Cell and Cancer Research Unity, Department of Haematology & Bone Marrow Transplantation, St. Vincent's Hospital, Sydney, Australia
• Jerome A. Zack, Ph.D., Director, UCLA Center for AIDS Research (CFAR)
• Dong Sung An, M.D., Ph.D., Assistant Professor, UCLA School of Nursing; Core Director, UCLA CFAR 
• Dani Bolognesi, Ph.D., Chairman and CEO b3bio Inc.
• Michael Greenberg, Ph.D.,  Vice President, Research & Development at b3 bio, Inc
• Dorothee Von Laer, DrMed, Ph.D., Professor, Division of Virology, Innsbruck Medical University, Austria
• Irvin Chen, Ph.D., Director, UCLA AIDS Institute
• John Murray, Ph.D., Associate Professor, School of Mathematics & Statistics, University of New South Wales

CLINICAL ADVISORY TEAM

• Ronald T. Mitsuyasu, M.D., Director, UCLA Center for Clinical AIDS Research and Education Center (CARE)
• Jacob P. Lalezari, M.D., Director, Quest Clinical Research
• Gero Hutter, M.D., Institute of Transfusion Medicine and Immunology, Mannheim, Germany
• Louise A. Evans, M.B., B.S., Ph.D., FRACP, Staff Specialist, Clinical Immunology and Consultant Physician
• Donald B. Kohn, M.D., Director, Human Gene Medicine Program at UCLA; Professor, Department of Microbiology, Immunology & Molecular Genetics and Pediatrics, UCLA
• David Cooper, A.O. F.A.A., M.D., DSc, Director, Kirby Institute, Australia; Head of Immunology/HIV/Infectious Diseases Unit, St. Vincent's Hospital, Sydney, Australia
• Douglas Richman, M.D., Director, UCSD Center for AIDS Research (CFAR)
• Andra Miller, Ph.D., Director, Cell and Gene Therapies at Biologics Consulting Group
• Andrew Carr, M.D., Professor of Medicine, University of New South Wales, Sydney,  Australia
• David Hardy, M.D., Director, Division of Infectious Disease, Cedars-Sinai Medical Center; Associate Professor, UCLA David Geffen School of Medicine